Page last updated: 2024-08-26

fibrinogen and Atrial Fibrillation

fibrinogen has been researched along with Atrial Fibrillation in 87 studies

Research

Studies (87)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (3.45)	18.7374
1990's	13 (14.94)	18.2507
2000's	31 (35.63)	29.6817
2010's	27 (31.03)	24.3611
2020's	13 (14.94)	2.80

Authors

Authors	Studies
Margolin, E; Nicholson, P; Patel, TJ; Zaslavsky, K	1
Butenas, S; Gajos, G; Hanarz, M; Malinowski, KP; Pociask, E; Undas, A; Ząbczyk, MT	1
Bramer, WM; de Groot, NMS; de Maat, MPM; Geurts, S; Kavousi, M; Pezzullo, AM; Tilly, MJ	1
Chen, Y; Han, X; Xu, D; Ye, C	1
Ceglarz, K; Durlik, M; Gozdowska, J; Kosieradzki, M; Świder, R; Zduńczyk, D	1
Axmann, HD; Becker, K; Behrens, HM; Gericke, E; Martens, K; Meliß, RR; Müller-Marienburg, N; Röcken, C; Siebert, F; Tholey, A; Treitz, C; Urban, P	1
Bang, OY; Choi, JC; Choi, KH; Chung, JW; Heo, SH; Hwang, YH; Jung, JM; Kim, BJ; Kim, CK; Kim, GM; Kim, JM; Kim, JT; Kim, YJ; Nam, KW; Oh, K; Park, JH; Park, KY; Park, MS; Seo, WK; Song, TJ; Yu, S	1
Bao, J; Gao, Z; Hu, Y; Liu, W; Wang, L; Ye, L	1
Batakji, M; Theodore, D	1
Adamowicz, J; Dudzik-Płocica, A; Filipiak, KJ; Gorko, D; Kotkowski, M; Legosz, P; Płatek, AE; Ryś, A; Semczuk-Kaczmarek, K; Szymański, FM	1
Amri, K; Chippaux, JP	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Ahangar, H; Bassiri, HA; Gohari, S; Noohi Bezanjani, F; Reshadmanesh, T	1
Antanaviciute, A; Ashley, N; Barallobre-Barreiro, J; Bhattacharya, S; Casadei, B; Channon, KM; Clarke, MV; Davey, RA; Evans, N; Gillis, MA; Hulsurkar, M; Krasopoulos, G; Lahiri, SK; Lee, A; Mayr, M; Mead, A; Mehta, N; Menassa, DA; Moreira, LM; Nattel, S; Naud, P; Norris, M; Psarros, C; Redwood, C; Reilly, S; Robinson, P; Russell, PK; Sayeed, R; Simmons, A; Sirois, M; Sparrow, AJ; Takawale, A; Tardif, JC; Theofilatos, K; Wehrens, XHT; Zajac, JD	1
Chen, HJ; Chen, YB; Cheng, HR; Cheng, QQ; He, JC; Huang, GQ; Luan, XQ; Ruan, YT; Yuan, CX; Zeng, YY	1
Bagoly, Z; Bereczky, Z; Csanádi, Z; Csiba, L; Hajas, O; Kiss, A; Kovács, KB; Muszbek, L; Nagy-Baló, E; Sarkady, F; Tóth, NK	1
Lin, J; Liu, JF; Liu, M; Wei, CC; Yang, TT; Zhang, SH; Zhang, ST	1
Chen, L; Hu, X; Huang, J; Li, Y; Qiao, S; Wang, J; Wu, J; Xu, S	1
Arnold, N; Beutel, ME; Binder, H; Blankenberg, S; Eggebrecht, L; Göbel, S; Jünger, C; Lackner, KJ; Laubert-Reh, D; Münzel, T; Pfeiffer, N; Prochaska, JH; Schulz, A; Spronk, HM; Ten Cate, H; Wild, PS	1
He, Y; Ke, HH; Li, JY; Lv, XW; Wei, Z; Zhang, EH	1
Gotsadze, M; Mantskava, M; Momtselidze, N; Narsia, N	1
Fountzilas, C; George, J; Levine, R	1
Brodowski, K; Jaworski, K; Kosior, DA; Krzykwa, A; Opolski, G; Zylińska, E	1
Biasucci, LM; Cavaliere, F; Crea, F; Di Monaco, A; Glieca, F; Leo, M; Liuzzo, G; Massetti, M; Musaico, F; Narducci, ML; Pazzano, V; Pelargonio, G; Rebuzzi, AG; Rio, T; Scapigliati, A; Severino, A; Trotta, F	1
Alasady, M; Brooks, AG; Dang, J; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Wong, CX; Worthley, MI; Young, GD	1
Barclay, ML; Begg, EJ; Chin, PK; Jensen, BP; Patterson, DM; Wright, DF; Zhang, M	1
Bladbjerg, EM; Gram, J; Jespersen, J; Sidelmann, JJ; Skov, J	1
Al Rifai, M; Alonso, A; Astor, BC; Ballantyne, CM; Chen, LY; Halushka, MK; Hoogeveen, RC; Maruthur, N; Parrinello, CM; Schneider, AL; Selvin, E; Soliman, EZ	1
Cushman, M; Howard, G; Howard, VJ; O'Neal, WT; Safford, MM; Soliman, EZ; Zakai, NA	1
Meus, R; Sobczyk, D; Son, M; Undas, A	1
Cichowski, L; Sadowski, J; Salczyńska, D; Targoński, R	1
Di Leo, R; Di Rosa, S; Fazio, G; Ferrara, F; La Franca, ML; Mansueto, P; Mansueto, S; Novo, G; Novo, S	1
Arentz, T; Bürkle, G; Kalusche, D; Letsas, KP; Mihas, CC; Minners, J; Weber, R	1
Kazakevich, EV; Serdechnaia, EV; Tatarskiĭ, BA	1
Albert, CM; Buring, JE; Conen, D; Cook, NR; Everett, BM; Ridker, PM; Rose, L; Tedrow, UB	1
Akdeniz, B; Aslan, A; Badak, O; Bariş, N; Bozdemir, V; Güneri, S; Kala, V; Kirimli, O; Ozel, E; Senarslan, O; Ulgenalp, A	1
Fu, R; Qiu, J; Wu, P; Wu, S	1
Agarwal, SK; Alonso, A; Chamberlain, AM; Folsom, AR; Soliman, EZ; Tang, W	1
Adamsson Eryd, S; Engström, G; Hedblad, B; Melander, O; Smith, JG	1
Akilli, H; Alihanoglu, Y; Altunkeser, BB; Aribas, A; Ayhan, S; Can, I; Demir, K; Koc, F; Vatankulu, MA	1
Baker, WL; Chen, WT; Colby, JA; Coleman, CI; Kluger, J; Reinhart, K; White, CM	1
Amerikanou, R; Besser, MW; Large, S; Lawrence, K; MacDonald, S	1
Eriksson, M; Järemo, P; Lindahl, TL; Milovanovic, M; Nilsson, S	1
Hansen, JB; Jørgensen, L; Løchen, ML; Mathiesen, EB; Njølstad, I; Nyrnes, A; Skjelbakken, T; Wilsgaard, T	1
Blann, AD; Chin, BS; Kamath, S; Lip, GY	1
Chin, BS; Conway, DS; Heeringa, J; Hofman, A; Lip, GY; Van Der Kuip, DA; Witteman, JC	1
Bertazzoni, G; Diurni, V; Placido, A; Rosa, A	1
Lip, GY; Marín, F; Roldán, V	1
Cangemi, R; Di Lecce, VN; Fimognari, FL; Loffredo, L; Violi, F	1
Akimoto, H; Baba, S; Fukuchi, M; Kagaya, Y; Kumagai, K; Oda, K; Ohta, J; Shirato, K; Tabayashi, K; Watanabe, J	1
Chang, H; Hung, CR; Wang, TL	1
Copplestone, A; Gilbert, TJ; Haywood, GA; Jacob, K; Talwar, S	1
Corral, J; del Rey, ML; González-Conejero, R; Lip, GY; Marín, F; Roldán, V; Sogorb, F; Vicente, V	1
Cases, A	1
Dimitroula, V; Goudevenos, JA; Karanikis, P; Kolettis, TM; Korantzopoulos, P; Kountouris, E; Pappa, E; Siogas, K	1
Boos, CJ; Lip, GY	1
Goudevenos, JA; Kolettis, TM; Korantzopoulos, P; Kountouris, E; Siogas, K	1
García, A; Lip, GY; Marín, F; Roldán, V; Tello-Montoliu, A	1
Akdemir, O; Demir, M; Ekuklu, G; Ozbay, G; Turgut, B; Turgut, N; Utku, U; Vural, O	1
Friberg, J; Grønbaek, M; Jensen, G; Mukamal, KJ; Tolstrup, JS	1
Breteler, MM; Conway, DS; Heeringa, J; Hofman, A; Lip, GY; van der Kuip, DA; Witteman, JC	1
Davis, G; Kaplan, K; Kwaan, HC	1
Beamer, NB; Briley, DP; Clark, WM; Coull, BM; Edwards, JM; Giraud, GD; Grauer, SE; Sexton, GJ; Spear, EM	1
Dunn, FG; Lip, GY; Lowe, GD; Rumley, A	3
Miyahara, K; Sohara, H	1
Black, IW; Chesterman, CN; Chong, BH; Hopkins, AP; Lee, LC; Walsh, WF	1
Flegel, KM; Kahn, SR; Solymoss, S	1
Asanuma, H; Funaya, H; Hori, M; Kitakaze, M; Koretsune, Y; Minamino, T; Sato, H	1
Fukazawa, H; Ikesa, U; Shimada, K; Yamamoto, K	1
Blann, AD; Goldsmith, I; Li-Saw-Hee, FL; Lip, GY	1
Carter, AM; Catto, AJ; Grant, PJ	1
Peverill, RE; Smolich, JJ	1
Bovill, EG; Cornell, ES; Cushman, M; Feinberg, WM; Hart, RG; Lip, GY; Pearce, LA	1
Blann, AD; Li-Saw-Hee, FL; Lip, GY	2
Blann, AD; Foo, LS; Goldsmith, IR; Lip, GY	1
Agricola, E; Ammaturo, T; Barbati, R; Fineschi, D; Guerrini, F; Mondillo, S; Nami, R; Pastore, M; Sabatini, L	1
Benjamin, EJ; D'Agostino, RB; Feng, D; Levy, D; Lipinska, I; Massaro, J; Silbershatz, H; Tofler, GH; Wolf, PA	1
Blann, AD; Edmunds, E; Gibbs, CR; Li-Saw-Hee, FL; Lip, GY	1
Aznar, J; Fernández, A; Martínez, M; Mira, Y; Moscardó, F; Ripoll, F; Vayá, A	1
Al-Saady, NM; Sopher, M	1
Blann, AD; Gurney, D; Li-Saw-Hee, FL; Lip, GY	1
Bellini, MA; Boschi, L; Donati, G; Forconi, S; Guerrini, M; Lapi, A; Ricci, D; Trabalzini, L; Turchetti, V	1
Nakagawa, M; Sawada, S; Toyoda, T; Tsuji, H; Uno, M	1
Alekseeva, LA; Lebedeva, RN; Svirshchevskiĭ, EB; Zaikina, LV	1

Reviews

5 review(s) available for fibrinogen and Atrial Fibrillation

Article	Year
The association of coagulation and atrial fibrillation: a systematic review and meta-analysis. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023, 02-08, Volume: 25, Issue:1 Topics: Atrial Fibrillation; Biomarkers; Blood Coagulation Factors; Cross-Sectional Studies; Fibrinogen; Humans; Plasminogen Activator Inhibitor 1; Thrombosis	2023
Difficulties in the Diagnosis of Fibrinogen Aα-Chain Amyloidosis-Literature Review and Case Report of a Patient After Kidney Transplantation. Transplantation proceedings, 2023, Volume: 55, Issue:3 Topics: Aged; Amyloidosis; Atrial Fibrillation; Fibrinogen; Humans; Kidney Transplantation; Male; Plaque, Amyloid; Proteinuria	2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Fibrinolytic function and atrial fibrillation. Thrombosis research, 2003, Mar-15, Volume: 109, Issue:5-6 Topics: Atrial Fibrillation; Cardiovascular Diseases; Disease Susceptibility; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Insulin Resistance; Matrix Metalloproteinases; Plasminogen; Plasminogen Activator Inhibitor 1; Stroke; Thromboembolism; Tissue Plasminogen Activator	2003
[New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24 Suppl, Issue:6 Topics: Atrial Fibrillation; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Obesity; Risk Factors; Smoking	2004

Trials

7 trial(s) available for fibrinogen and Atrial Fibrillation

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients. Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:2 Topics: Adult; Aged; Atrial Appendage; Atrial Fibrillation; Blood Coagulation Tests; Female; Fibrinogen; Humans; Male; Middle Aged; Rivaroxaban; Thrombosis; Treatment Outcome; Warfarin	2019
Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2011, Volume: 20, Issue:5 Topics: Analysis of Variance; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Chronic Disease; Electric Countershock; Female; Fibrinogen; Health Status Indicators; Heptanoic Acids; Humans; Leukocyte Count; Male; Middle Aged; Pyrroles; Secondary Prevention; Time Factors; Warfarin	2011
Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Sep-01, Volume: 68, Issue:17 Topics: Aged; Ascorbic Acid; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Cardiac Surgical Procedures; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Female; Fibrinogen; Heart Valve Diseases; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Vitamins	2011
Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. International journal of cardiology, 2005, Jul-10, Volume: 102, Issue:2 Topics: Administration, Oral; Aged; Antioxidants; Ascorbic Acid; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Echocardiography; Electric Countershock; Electrocardiography; Female; Ferritins; Fibrinogen; Follow-Up Studies; Heart Atria; Humans; Incidence; Inflammation; Leukocyte Count; Male; Myocarditis; Nephelometry and Turbidimetry; Oxidative Stress; Prospective Studies; Secondary Prevention; Treatment Outcome	2005
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. British heart journal, 1995, Volume: 73, Issue:6 Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Chronic Disease; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Thrombosis; von Willebrand Factor; Warfarin	1995
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation. Stroke, 2000, Volume: 31, Issue:4 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Prospective Studies; Reference Values; Thrombosis; von Willebrand Factor; Warfarin	2000

Other Studies

76 other study(ies) available for fibrinogen and Atrial Fibrillation

Article	Year
Hypercoagulability in patients with indirect carotid cavernous fistulas. Eye (London, England), 2022, Volume: 36, Issue:10 Topics: Antibodies, Anticardiolipin; Antithrombin III; Atrial Fibrillation; Female; Fibrinogen; Fistula; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Protein C; Prothrombin; Thrombophilia	2022
Active FXI Can Independently Predict Ischemic Stroke in Anticoagulated Atrial Fibrillation Patients: A Cohort Study. Thrombosis and haemostasis, 2022, Volume: 122, Issue:8 Topics: Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Factor XI; Fibrinogen; Humans; Interleukin-6; Ischemic Stroke; Middle Aged; Risk Factors; Thromboplastin; von Willebrand Factor	2022
Early myocardial injury and coagulation activation in thoracoscopic left atrial appendage clipping. Journal of cardiac surgery, 2022, Volume: 37, Issue:12 Topics: Atrial Appendage; Atrial Fibrillation; Fibrinogen; Humans; Stroke; Treatment Outcome; Troponin I	2022
ATTR- and AFib amyloid - two different types of amyloid in the annular ligament of trigger finger. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2023, Volume: 30, Issue:4 Topics: Amyloid; Amyloidogenic Proteins; Atrial Fibrillation; Fibrinogen; Humans; Ligaments; Proteomics; Trigger Finger Disorder	2023
D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation. Thrombosis research, 2023, Volume: 229 Topics: Atrial Fibrillation; Brain Ischemia; Fibrinogen; Humans; Ischemic Stroke; Prospective Studies; Risk Factors; Stroke	2023
Serum fibrinogen-to-albumin ratio predicts new-onset atrial fibrillation risk during hospitalization in patients with acute myocardial infarction after percutaneous coronary intervention: a retrospective study. BMC cardiovascular disorders, 2023, 09-01, Volume: 23, Issue:1 Topics: Albumins; Atrial Fibrillation; Fibrinogen; Hospitalization; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Retrospective Studies	2023
Hemorrhagic Shock After Lumbar Puncture. Neurocritical care, 2019, Volume: 31, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Central Nervous System Diseases; Computed Tomography Angiography; Enoxaparin; Erythrocyte Transfusion; Factor VIII; Factor Xa Inhibitors; Female; Fibrinogen; Fluid Therapy; Heparin; Humans; Middle Aged; Plasma; Postoperative Complications; Pyrazoles; Pyridones; Radiology, Interventional; Retroperitoneal Space; Sarcoidosis; Shock, Hemorrhagic; Spinal Puncture	2019
CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2019, Volume: 28, Issue:11 Topics: Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Female; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors; Stroke; Survival Analysis; Thromboembolism; Time Factors; Treatment Outcome	2019
Report of a severe Clinical toxicology (Philadelphia, Pa.), 2021, Volume: 59, Issue:4 Topics: Adult; Animals; Atrial Fibrillation; Bites and Stings; Edema; Fibrinogen; Humans; Lizards; Male; Venoms	2021
Risk Factors Associated with Heart Valve Thrombosis in Patients with Prosthetic Heart Valve Dysfunction. Archives of Iranian medicine, 2020, 09-01, Volume: 23, Issue:9 Topics: Adult; Anticoagulants; Atrial Fibrillation; Cross-Sectional Studies; Female; Fibrinogen; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Iran; Logistic Models; Male; Middle Aged; Risk Assessment; Risk Factors; Thrombosis	2020
Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia. Nature, 2020, Volume: 587, Issue:7834 Topics: Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Calcitonin; Collagen Type I; Female; Fibrinogen; Fibroblasts; Fibrosis; Heart Atria; Humans; Male; Mice; Myocardium; Myocytes, Cardiac; Paracrine Communication; Receptors, Calcitonin	2020
Hemostasis functions are associated with hemorrhagic transformation in non-atrial fibrillation patients: a case-control study. BMC neurology, 2021, Jan-26, Volume: 21, Issue:1 Topics: Aged; Atrial Fibrillation; Case-Control Studies; Cerebral Hemorrhage; Female; Fibrinogen; Hemostasis; Humans; Ischemic Stroke; Magnetic Resonance Imaging; Male; Mean Platelet Volume; Middle Aged; Platelet Count; Retrospective Studies; Risk Factors	2021
Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation. BioMed research international, 2017, Volume: 2017 Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Factor VIII; Factor XIII; Female; Femoral Vein; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Heart Atria; Hemostasis; Humans; Male; Middle Aged; Peptide Hydrolases; Tachycardia, Supraventricular; Thromboembolism; von Willebrand Factor	2017
Association between Fibrinogen and Leukoaraiosis in Patients with Ischemic Stroke and Atrial Fibrillation. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2017, Volume: 26, Issue:11 Topics: Aged; Atrial Fibrillation; Brain; Brain Ischemia; Female; Fibrinogen; Humans; Leukoaraiosis; Magnetic Resonance Imaging; Male; Middle Aged; Odds Ratio; Severity of Illness Index; Stroke	2017
The β-fibrinogen gene 455G/A polymorphism associated with cardioembolic stroke in atrial fibrillation with low CHA Scientific reports, 2017, 12-13, Volume: 7, Issue:1 Topics: 5-Lipoxygenase-Activating Proteins; Aged; Atrial Fibrillation; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Intracranial Embolism; Male; Matrix Metalloproteinase 9; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Risk Assessment; Stroke	2017
Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study. Journal of the American Heart Association, 2018, 09-04, Volume: 7, Issue:17 Topics: Adrenomedullin; Adult; Aged; Ankle Brachial Index; Anticoagulants; Asymptomatic Diseases; Atrial Fibrillation; Atrial Natriuretic Factor; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Fibrinogen; Germany; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenprocoumon; Protein Precursors; Pulmonary Embolism; Risk Factors; Stroke; Stroke Volume; Vascular Stiffness; Venous Thrombosis; Warfarin	2018
MONITORING OF HEMORHEOLOGICAL PARAMETERS IN PATIENTS WITH ATRIAL FIBRILLATION (INITIAL DATA). Georgian medical news, 2019, Issue:290 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Viscosity; Case-Control Studies; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Rheology	2019
Dabigatran overdose secondary to acute kidney injury and amiodarone use. The New Zealand medical journal, 2013, Mar-01, Volume: 126, Issue:1370 Topics: Acute Kidney Injury; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Creatinine; Dabigatran; Drug Overdose; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Thrombin Time	2013
[Role of inflammation in etiology of atrial fibrillation--is lone arrhythmia really alone]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:4 Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrroles; Recurrence	2012
Predictors of postoperative atrial fibrillation in patients with coronary artery disease undergoing cardiopulmonary bypass: a possible role for myocardial ischemia and atrial inflammation. Journal of cardiothoracic and vascular anesthesia, 2014, Volume: 28, Issue:3 Topics: Aged; Atrial Fibrillation; C-Reactive Protein; Cardiopulmonary Bypass; Coronary Artery Disease; Female; Fibrinogen; Heart Atria; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Ischemia; Myocarditis; Postoperative Complications; Prospective Studies; Risk Factors	2014
Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. Circulation. Arrhythmia and electrophysiology, 2014, Volume: 7, Issue:1 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Catheter Ablation; Creatine Kinase, MB Form; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Injuries; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; Troponin T	2014
Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran. British journal of clinical pharmacology, 2014, Volume: 78, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Female; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Partial Thromboplastin Time; Pyridines; Thrombin Time	2014
Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation. Thrombosis research, 2014, Volume: 134, Issue:3 Topics: Aged; Anticoagulants; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Risk Factors; Stroke; Thrombin	2014
sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study. Journal of diabetes and its complications, 2015, Volume: 29, Issue:2 Topics: Atherosclerosis; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Female; Fibrinogen; gamma-Glutamyltransferase; Humans; Incidence; Inflammation Mediators; Male; Middle Aged; Models, Biological; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors; Solubility; United States	2015
Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study. Atherosclerosis, 2015, Volume: 243, Issue:1 Topics: Aged; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Disease; Ethnicity; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Geography; Hemostasis; Humans; Inflammation; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke	2015
Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events. Stroke, 2016, Volume: 47, Issue:7 Topics: Adult; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Blood Coagulation Factors; Brain Ischemia; Case-Control Studies; Comorbidity; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Foramen Ovale, Patent; Heart Diseases; Humans; Ischemic Attack, Transient; Male; Middle Aged; Migraine Disorders; Platelet Count; Smoking; Stroke Volume; Thrombin; Thrombophilia; Thrombosis	2016
Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure. Kardiologia polska, 2008, Volume: 66, Issue:7 Topics: Aged; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Female; Fibrinogen; Heart Atria; Heart Failure; Humans; Hypertension; Male; Stroke Volume; Systole; Ultrasonography	2008
Risk factors, atrial fibrillation and thromboembolic events. International angiology : a journal of the International Union of Angiology, 2008, Volume: 27, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Diabetes Complications; Female; Fibrinogen; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Obesity; Risk Factors; Smoking; Thromboembolism; Young Adult	2008
Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:2 Topics: Atrial Fibrillation; C-Reactive Protein; Catheter Ablation; Female; Fibrinogen; Follow-Up Studies; Heart Atria; Heart Ventricles; Humans; Hypertension; Inflammation; Leukocyte Count; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Recurrence; Regression Analysis; Retrospective Studies; Risk Factors; Ventricular Dysfunction, Left	2009
[Genetic polymorphism and risk of arterial thrombosis in patients with atrial fibrillation]. Klinicheskaia meditsina, 2008, Volume: 86, Issue:12 Topics: Atrial Fibrillation; Brain Ischemia; Coronary Thrombosis; DNA; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Russia	2008
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. European heart journal, 2010, Volume: 31, Issue:14 Topics: Atrial Fibrillation; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors	2010
The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2010, Volume: 10, Issue:3 Topics: Adenine; Aged; Atrial Fibrillation; Coronary Thrombosis; Cross-Sectional Studies; Diabetes Complications; Echocardiography, Transesophageal; Female; Fibrinogen; Guanine; Humans; Hypertension; Male; Middle Aged; Mitral Valve Stenosis; Polymorphism, Single Nucleotide; Thromboembolism	2010
A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:1 Topics: Adult; Anticoagulants; Atrial Fibrillation; Biomarkers; Case-Control Studies; Female; Fibrinogen; Humans; Male; Middle Aged; P-Selectin; Prognosis; Risk Factors; Thrombophilia; Thrombosis; von Willebrand Factor	2011
Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study. International journal of cardiology, 2012, Mar-08, Volume: 155, Issue:2 Topics: Antithrombin III; Atrial Fibrillation; Biomarkers; Brain Ischemia; Factor VII; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Partial Thromboplastin Time; Prognosis; Protein C; Risk Factors; Stroke; von Willebrand Factor	2012
Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study. European journal of epidemiology, 2011, Volume: 26, Issue:6 Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Atrial Fibrillation; Biomarkers; Ceruloplasmin; Cohort Studies; Complement C3; Complement C4; Fibrinogen; Follow-Up Studies; Haptoglobins; Hospitalization; Humans; Male; Middle Aged; Orosomucoid; Proportional Hazards Models; Risk Factors; Sweden	2011
THE PAPWORTH PLUG - successful use of high dose fibrinogen concentrate and platelet concentrate in potential life-threatening complication after cardiopulmonary bypass surgery in a patient with Type 2M Vicenza von Willebrand Disease. Perfusion, 2012, Volume: 27, Issue:4 Topics: Aged; Atrial Fibrillation; Blood Loss, Surgical; Cardiopulmonary Bypass; Fibrinogen; Heart Failure; Humans; Male; Platelet Transfusion; von Willebrand Disease, Type 2	2012
Platelets and acute cerebral infarction. Platelets, 2013, Volume: 24, Issue:5 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Platelets; Cerebral Infarction; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Neutrophils; P-Selectin; Platelet Activation; Platelet Count; Prospective Studies; Protein Binding; Stroke	2013
Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. Gender medicine, 2012, Volume: 9, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Disease; Electrocardiography; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Norway; Osteoprotegerin; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Factors	2012
A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:7 Topics: Aged; Atrial Fibrillation; beta-Thromboglobulin; Blood Viscosity; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Platelet Activation; Risk Factors; Thrombophilia	2002
Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study. Stroke, 2003, Volume: 34, Issue:2 Topics: Aged; Atrial Fibrillation; Biomarkers; Case-Control Studies; Cohort Studies; Comorbidity; Disease Susceptibility; Female; Fibrinogen; Humans; Male; Netherlands; Odds Ratio; P-Selectin; Predictive Value of Tests; Risk Factors; Sex Distribution; Sex Factors; Thrombosis; von Willebrand Factor	2003
Markers of inflammation in atrial fibrillation. Acta cardiologica, 2003, Volume: 58, Issue:1 Topics: Acute-Phase Reaction; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Electric Countershock; Fibrinogen; Humans; Risk Factors	2003
Fibrinogen as predictor of ischemic stroke in patients with non-valvular atrial fibrillation. Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:11 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Fibrinogen; Humans; Middle Aged; Predictive Value of Tests; Risk Factors; Stroke	2003
Expression of the von Willebrand factor in atrial endocardium is increased in atrial fibrillation depending on the extent of structural remodeling. Circulation journal : official journal of the Japanese Circulation Society, 2004, Volume: 68, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Atrial Appendage; Atrial Fibrillation; Atrial Function; Endocardium; Female; Fibrin; Fibrinogen; Gene Expression; Heart Atria; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Messenger; Thrombophilia; von Willebrand Factor	2004
Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation. Cardiology, 2004, Volume: 102, Issue:2 Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Fibrillation; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Time Factors	2004
Activation of coagulation occurs after electrical cardioversion in patients with chronic atrial fibrillation despite optimal anticoagulation with warfarin. International journal of cardiology, 2004, Volume: 95, Issue:1 Topics: Adult; Aged; Anticoagulants; Antithrombin III; Atrial Fibrillation; Biomarkers; Blood Coagulation; Chronic Disease; Electric Countershock; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Protein C; Treatment Outcome; United Kingdom; Warfarin	2004
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. Journal of molecular and cellular cardiology, 2004, Volume: 37, Issue:3 Topics: Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Atrial Fibrillation; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Inflammation; Interleukin-6; Male; P-Selectin; Polymorphism, Genetic; Thromboplastin	2004
The role of inflammation in atrial fibrillation. International journal of clinical practice, 2005, Volume: 59, Issue:8 Topics: Aged; Antioxidants; Ascorbic Acid; Atrial Fibrillation; Biomarkers; Fibrinogen; Humans; Inflammation; Interleukin-6; Middle Aged; Thromboembolism	2005
Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates? International journal of clinical practice, 2005, Volume: 59, Issue:8 Topics: Aged; Analysis of Variance; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Echocardiography; Electric Countershock; Female; Fibrinogen; Humans; Leukocyte Count; Male; Prospective Studies; Recurrence	2005
Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation? International journal of cardiology, 2006, Jun-16, Volume: 110, Issue:2 Topics: Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Humans; Interleukin-6; Linear Models; Male; Multivariate Analysis; Prothrombin; Risk Factors; Thrombophilia; von Willebrand Factor	2006
Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2006, Volume: 12, Issue:1 Topics: Aged; Atrial Fibrillation; Case-Control Studies; Drug Evaluation; Female; Fibrinogen; Humans; Middle Aged; Peptide Fragments; Prothrombin; Severity of Illness Index; Stroke; Thrombophilia	2006
Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). The American journal of cardiology, 2006, Jul-01, Volume: 98, Issue:1 Topics: Aged; Albumins; Atrial Fibrillation; Biomarkers; Cohort Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors	2006
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999. Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:9 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation Factors; Case-Control Studies; Cohort Studies; Death; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Netherlands; P-Selectin; Proportional Hazards Models; Risk Factors; Stroke; Thrombophilia; Thrombosis; von Willebrand Factor	2006
Pulmonary emboli from a platelet-rich thrombus attached to a pacemaker electrode. Pacing and clinical electrophysiology : PACE, 1983, Volume: 6, Issue:5 Pt 1 Topics: Atrial Fibrillation; Electrodes, Implanted; Fibrinogen; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Pacemaker, Artificial; Plasminogen Activators; Platelet Aggregation; Pulmonary Embolism; Vena Cava, Superior	1983
Spontaneous echo contrast and hemorheologic abnormalities in cerebrovascular disease. Stroke, 1994, Volume: 25, Issue:8 Topics: Aged; Atrial Fibrillation; Blood Viscosity; Cerebrovascular Disorders; Echocardiography; Female; Fibrinogen; gamma-Globulins; Hematocrit; Hemorheology; Humans; Ischemic Attack, Transient; Leukocyte Count; Male; Middle Aged; Platelet Count; Serum Albumin	1994
Effect of atrial fibrillation on the fibrino-coagulation system--study in patients with paroxysmal atrial fibrillation. Japanese circulation journal, 1994, Volume: 58, Issue:11 Topics: Aged; Antithrombin III; Atrial Fibrillation; beta-Thromboglobulin; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Peptide Hydrolases; Platelet Factor 4; Prothrombin Time	1994
Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. Journal of the American College of Cardiology, 1993, Volume: 21, Issue:2 Topics: Aged; Atrial Fibrillation; Atrial Function, Left; Echocardiography; Erythrocyte Aggregation; Female; Fibrinogen; Heart Atria; Hematocrit; Humans; Male; Multivariate Analysis; Risk Factors; Thromboembolism	1993
Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm. International journal of cardiology, 1995, Volume: 51, Issue:3 Topics: Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Atrial Fibrillation; Cerebrovascular Disorders; Electric Countershock; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Heart Rate; Heparin; Humans; Male; Middle Aged; Prospective Studies; Thromboembolism; Warfarin	1995
Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. American heart journal, 1996, Volume: 131, Issue:4 Topics: Aged; Antifibrinolytic Agents; Atrial Fibrillation; Cross-Sectional Studies; Echocardiography; Fibrinogen; Humans; Male; Middle Aged; Tachycardia, Paroxysmal; Tachycardia, Supraventricular	1996
Nonvalvular atrial fibrillation: evidence for a prothrombotic state. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1997, Sep-15, Volume: 157, Issue:6 Topics: Aged; Anticoagulants; Antithrombin III; Atrial Fibrillation; Cross-Sectional Studies; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Hemoglobins; Hemostasis; Humans; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Male; Partial Thromboplastin Time; Peptide Fragments; Platelet Count; Protein C; Protein S; Prothrombin; Prothrombin Time; von Willebrand Factor; Warfarin	1997
Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11 Topics: Aged; Atrial Fibrillation; beta-Thromboglobulin; Blood Platelets; Blood Proteins; Cerebrovascular Disorders; Comorbidity; Cyclic GMP; Diabetes Mellitus; Echocardiography; Female; Fibrinogen; Hemodynamics; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Ischemia; Nitrates; Nitric Oxide; Nitrites; Risk Factors; Smoking; Thrombophilia	1997
Hemostatic markers in heart disease. American heart journal, 1998, Volume: 135, Issue:2 Pt 1 Topics: Atrial Fibrillation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Diseases; Hemostasis; Humans	1998
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis. The American journal of cardiology, 1999, Apr-15, Volume: 83, Issue:8 Topics: Atrial Fibrillation; beta-Thromboglobulin; Biomarkers; Blood Coagulation Factors; Blood Vessels; Catheterization; Female; Fibrin; Fibrinogen; Heart Atria; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve Stenosis; P-Selectin; Platelet Activation; Prognosis; Retrospective Studies; Risk Factors; Thrombophilia	1999
Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation, 1999, May-11, Volume: 99, Issue:18 Topics: Amino Acid Substitution; Atrial Fibrillation; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Point Mutation; Polymorphism, Genetic; Risk; Risk Factors; Smoking; Survival Analysis; Thromboembolism; Thrombophilia; Transglutaminases	1999
Relation between atrial coagulation activity and levels of coagulation markers in peripheral samples. The American journal of cardiology, 1999, Sep-15, Volume: 84, Issue:6 Topics: Atrial Fibrillation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Atria; Humans; Mitral Valve Stenosis; Predictive Value of Tests; Thrombin; Thrombosis	1999
Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke, 1999, Volume: 30, Issue:12 Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; beta-Thromboglobulin; Biomarkers; Factor V; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Multivariate Analysis; Peptide Fragments; Phlebotomy; Prothrombin; Sex Factors; Stroke; Thromboembolism; Warfarin	1999
Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty. Clinical cardiology, 2000, Volume: 23, Issue:8 Topics: Atrial Fibrillation; Catheterization; Chronic Disease; Endothelium, Vascular; Female; Fibrinogen; Humans; Male; Middle Aged; Mitral Valve Stenosis; P-Selectin; Platelet Activation; von Willebrand Factor	2000
Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation. The American journal of cardiology, 2000, Oct-01, Volume: 86, Issue:7 Topics: Aged; Atrial Fibrillation; Blood Coagulation; Blood Pressure; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; von Willebrand Factor	2000
Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation. International journal of cardiology, 2000, Sep-15, Volume: 75, Issue:2-3 Topics: Aged; Atrial Fibrillation; Biomarkers; Chronic Disease; Endothelium, Vascular; Female; Fibrinogen; Heart Atria; Hemodynamics; Humans; Male; Middle Aged; Plasminogen Inactivators; Platelet Activation; von Willebrand Factor	2000
Hemostatic state and atrial fibrillation (the Framingham Offspring Study). The American journal of cardiology, 2001, Jan-15, Volume: 87, Issue:2 Topics: Aged; Atrial Fibrillation; Blood Coagulation Factors; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Thromboembolism; Tissue Plasminogen Activator; von Willebrand Factor	2001
Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation. Clinical cardiology, 2001, Volume: 24, Issue:5 Topics: Adult; Aged; Atrial Fibrillation; Chronic Disease; Exercise; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; P-Selectin; von Willebrand Factor	2001
The effect of acenocoumarol on hemorheological parameters. Clinical hemorheology and microcirculation, 2001, Volume: 24, Issue:2 Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Atrial Fibrillation; Blood Viscosity; Drug Evaluation; Erythrocyte Indices; Female; Fibrinogen; Hemorheology; Humans; International Normalized Ratio; Male; Middle Aged; Prospective Studies; Safety	2001
Prothrombotic markers in atrial fibrillation: what is new? European heart journal, 2001, Volume: 22, Issue:18 Topics: Atrial Fibrillation; Biomarkers; Chronic Disease; Fibrinogen; Humans; P-Selectin; Stroke; von Willebrand Factor	2001
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. European heart journal, 2001, Volume: 22, Issue:18 Topics: Adult; Aged; Atrial Fibrillation; Atrial Function, Left; Biomarkers; Chronic Disease; Cross-Sectional Studies; Echocardiography, Doppler; Electric Countershock; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; P-Selectin; Predictive Value of Tests; Regression Analysis; von Willebrand Factor	2001
Spontaneous echo-contrast as an in vivo indicator of rheological imbalance in dilatative cardiomyopathy. Clinical hemorheology and microcirculation, 2001, Volume: 25, Issue:3-4 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Viscosity; Cardiomyopathy, Dilated; Cardiovascular Agents; Echocardiography, Transesophageal; Erythrocytes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Atria; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Risk Factors; Stroke; Stroke Volume	2001
Fibrinopeptide A (FPA) levels in atrial fibrillation and the effects of heparin administration. Japanese circulation journal, 1988, Volume: 52, Issue:1 Topics: Atrial Fibrillation; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Hypertension; Mitral Valve Stenosis	1988
[Arrhythmia following thoracic surgery]. Kardiologiia, 1971, Volume: 11, Issue:11 Topics: Age Factors; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Blood Coagulation; Blood Pressure; Blood Volume; Calcium; Cardiac Output; Cardiac Surgical Procedures; Fibrinogen; Fibrinolysis; Heart Rate; Heparin; Humans; Middle Aged; Mitral Valve Stenosis; Postoperative Complications; Tachycardia, Paroxysmal; Thoracic Diseases	1971